CASI Pharmaceuticals Total Assets Growth & History (CASIF)

CASI Pharmaceuticals's total assets was $25.6M for fiscal 2025.

View full CASI Pharmaceuticals company overview

CASI Pharmaceuticals annual total assets history

CASI Pharmaceuticals annual total assets

Fiscal yearPeriod endedTotal assetsChangeGrowth
20252025-12-31$25.6M−$28.0M−52.21%
20242024-12-31$53.7M−$21.6M−28.69%
20232023-12-31$75.3M−$21.0M−21.79%
20222022-12-31$96.2M−$42.1M−30.42%
20212021-12-31$138.3M

CASI Pharmaceuticals total assets trends

Between the periods ended 2021-12-31 and 2025-12-31, CASI Pharmaceuticals's total assets decreased from $138.3M to $25.6M, a change of −$112.6M. The latest reported quarter, Q2 2026, shows $21.1M.

About the metric

What total assets mean

Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.

Calculation and source

SEC-reported total assets

TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review CASI Pharmaceuticals source filings ↗

Community posts

It’s quiet here.

No posts about CASIF yet. Start the conversation.

Write the first post